• 1
    Ginès P, Schrier RW. The arterial vasodilation hypothesis of ascites formation in cirrhosis. In: ArroyoV, GinèsP, RodésJ, SchrierRW, eds. Ascites and Renal Dysfunction in Liver Disease. Massachusetts: Blackwell Science, 1999: 411427.
  • 2
    Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of sodium and water retention in cirrhosis. HEPATOLOGY 1988; 8: 11511157.
  • 3
    Martin PY, Ginès P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998; 339: 533541.
  • 4
    Martin PY, Ohara M, Ginès P, Xu DL, St John J, Niederberger M, Schrier RW. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. J Clin Invest 1998; 101: 235242.
  • 5
    Arroyo V, Jiménez W. Complications of cirrhosis II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol 2000; 32(Suppl 1): 157170.
  • 6
    Bosch J, Garcia-Pagan JC. Complications of cirrhosis I. Portal hypertension. J Hepatol 2000; 32(Suppl 1): 141156.
  • 7
    Wiest R, Groszmann RJ. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance. Semin Liver Dis 1999; 19: 411426.
  • 8
    Moreau R, Lebrec D. Endogenous factors involved in the control of arterial tone in cirrhosis. J Hepatol 1995; 22: 370376.
  • 9
    Fernández M, Bonkovsky HL. Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats. HEPATOLOGY 1999; 29: 16721679.
  • 10
    Fernández M, Lambrecht RW, Bonkovsky HL. Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity. J Hepatol 2001; 34: 812817.
  • 11
    De las Heras D, Fernández J, Ginès P, Cárdenas A, Ortega R, Navasa M, Barberà JA, et al. Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis. A possible mediator of circulatory dysfunction. HEPATOLOGY 2003; 38: 452459.
  • 12
    Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37: 517554.
  • 13
    Suematsu M, Ishimura Y. The heme oxygenase-carbon monoxide system: a regulator of hepatobiliary function. HEPATOLOGY 2000; 31: 36.
  • 14
    Naik JS, Walter BR. Heme oxygenase-mediated vasodilation involves vascular smooth muscle cell hyperpolarization. Am J Physiol Heart Circ Physiol 2003; 285: H220H228.
  • 15
    Ishizaka N, de Leon H, Laureen JB, Fukui T, Wilcox JN, De Keulenaer G, Griendling KK, et al. Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation 1997; 96: 19231929.
  • 16
    Zakhary R, Gaine SP, Dinerman JL, Ruat M, Flavahan NA, Snyder SH. Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci U S A 1996; 93: 795798.
  • 17
    Cruse I, Maines MD. Evidence suggesting that the two forms of heme oxygenase are products of different genes. J Biol Chem 1988; 263: 33483353.
  • 18
    Niederberger M, Ginès P, Martin PY, Tsai P, Morris K, McMurtry I, Schrier RW. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. HEPATOLOGY 1996; 24: 947951.
  • 19
    Lee SS, Girod C, Braillon A, Hadengue A, Lebrec D. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium. Am J Physiol 1986; 251: G176G180.
  • 20
    Johnson RA, Lavesa M, Askari B, Abraham NG, Nasjletti A. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 1995; 25: 166169.
  • 21
    Motterlini R, Gonzales A, Foresti R, Clark JE, Green CJ, Winslow RM. Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res 1998; 83: 568577.
  • 22
    Liu H, Song D, Lee SS. Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat. Am J Physiol Gastrointest Liver Physiol 2001; 280: G68G74.
  • 23
    Bonkovsky HL, Healey JF, Pohl J. Purification and characterization of heme oxygenase from chick liver. Comparison of the avian and mammalian enzymes. Eur J Biochem 1990; 189: 155166.
  • 24
    Carter EP, Hartsfield CL, Miyazono M, Jakkula M, Morris KG Jr, McMurtry IF. Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol 2002; 283: L346L353.
  • 25
    Cadnapaphornchai MA, Kim YW, Gurevich AK, Summer SN, Falk S, Thurman JM, Schrier RW. Urinary concentrating defect in hypothyroid rats: role of sodium, potassium, 2-chloride co-transporter, and aquaporins. J Am Soc Nephrol 2003; 14: 566574.
  • 26
    Slama M, Susic D, Varagic J, Ahn J, Frohlich ED. Echocardiographic measurement of cardiac output in rats. Am J Physiol Heart Circ Physiol 2003; 284: H691H697.
  • 27
    Martinez-Prieto C, Ortiz MC, Fortepiani LA, Ruiz-Macia J, Atucha NM, Garcia-Estan J. Haemodynamic and renal evolution of the bile duct-ligated rat. Clin Sci 2000; 98: 611617.
  • 28
    Miyazono M, Garat C, Morris KG Jr, Carter EP. Decreased renal heme oxygenase-1 expression contributes to decreased renal function during cirrhosis. Am J Physiol Renal Physiol 2002; 283: F1123F1131.
  • 29
    Naik JS, O'Donaughy TL, Walker BR. Endogenous carbon monoxide is an endothelial-derived vasodilator factor in the mesenteric circulation. Am J Physiol Heart Circ Physiol 2003; 284: H838H845.
  • 30
    Durante W, Kroll MH, Christodoulides N, Peyton KJ, Schafer AI. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res 1997; 80: 557564.
  • 31
    Morita T, Perrella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci U S A 1995; 92: 14751479.
  • 32
    Sammut IA, Foresti R, Clark JE, Exon DJ, Vesely MJ, Sarathchandra P, Green CJ, et al. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br J Pharmacol 1998; 125: 14371444.
  • 33
    Coceani F, Kelsey L, Seidlitz E, Marks GS, McLaughlin BE, Vreman HJ, Stevenson DK, et al. Carbon monoxide formation in the ductus arteriosus in the lamb: implications for the regulation of muscle tone. Br J Pharmacol 1997; 120: 599608.
  • 34
    Marks GS, McLaughlin BE, Vreman HJ, Stevenson DK, Nakatsu K, Brien JF, Pang SC. Heme oxygenase activity and immunohistochemical localization in bovine pulmonary artery and vein. J Cardiovasc Pharmacol 1997; 30: 16.
  • 35
    Christodoulides N, Durante W, Kroll MH, Schafer AI. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation 1995; 91: 23062309.
  • 36
    Zhang F, Kaide JI, Rodriguez-Mulero F, Abraham NG, Nasjletti A. Vasoregulatory function of the heme-heme oxygenase-carbon monoxide system. Am J Hypertens 2001; 14: 62S67S.
  • 37
    Yet SF, Pellacani A, Patterson C, Tan L, Folta SC, Foster L, Lee WS, et al. Induction of heme oxygenase-1 expression in vascular smooth muscle cells. A link to endotoxic shock. J Biol Chem 1997; 272: 42954301.
  • 38
    Sacerdoti D, Abraham NG, Oyekan AO, Yang L, Gatta A, McGiff JC. The role of the heme oxygenases in abnormalities of the mesenteric circulation in cirrhotic rats. J Pharmacol Exp Ther, in press.
  • 39
    Dos Santos EA, Yamaguishi GA, Heimann JC. Effect of the heme/heme oxygenase pathway on the relationship between salt consumption and blood pressure. J Hypertens 1998; 16: 19651969.
  • 40
    Harry R, Grieve D, Bowles M, Heaton N, Muiesan P, Rela M, Wendon J, et al. Splanchnic vascular hyporeactivity in human cirrhosis is related to disease severity and mediated by nitric oxide and carbon monoxide [abstract]. Gut 2002; 50(Suppl 2): 30A.
  • 41
    Shibahara S. Regulation of heme oxygenase gene expression. Semin Hematol 1988; 25: 370376.
  • 42
    Chu CJ, Lee FY, Wang SS, Lu RH, Tsai YT, Lin HC, Hou MC, et al. Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor-alpha and nitric oxide. Clin Sci 1997; 93: 219225.
  • 43
    Pastor A, Collado PS, Almar M, Gonzalez-Gallego J. Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine. J Hepatol 1997; 27: 363370.
  • 44
    Singh S, Shackleton G, Ah-Sing E, Chakraborty J, Bailey ME. Antioxidant defenses in the bile duct-ligated rat. Gastroenterology 1992; 103: 16251629.
  • 45
    Xu L, Carter EP, Ohara M, Martin PY, Rogachev B, Morris K, Cadnapaphornchai M, et al. Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis. Am J Physiol Renal Physiol 2000; 279: F1110F1115.
  • 46
    Johnson RA, Kozma F, Colombari E. Carbon monoxide: from toxin to endogenous modulator of cardiovascular functions. Braz J Med Biol Res 1999; 32: 114.
  • 47
    O'Donaughy TL, Walker BR. Renal vasodilatory influence of endogenous carbon monoxide in chronically hypoxic rats. Am J Physiol Heart Circ Physiol 2000; 279: H2908H2915.